OPKO Health Share Price: A Contradiction Between Short-Term Weakness and Long-Term DCF Upside

OPKO Health scores 2 out of 6 on our valuation checks, indicating it is undervalued by 73.5% on a Discounted Cash Flow (DCF) analysis. The DCF model projects negative free cash flow until 2028, then turns positive, reaching $78.30 million in 2029. The intrinsic value is estimated at $5.06 per share, with a 73.5% discount to the current share price.